Tens of thousands of Americans will soon be forced by their health insurance to switch from one popular obesity drug to another ... published on Sunday in The New England Journal of Medicine.

Swiss start-up Haya Therapeutics has formed a partnership with Eli Lilly – worth up to $1 billion – to look for new therapies for obesity in ... the 98% of human genetic material, sometimes ...

WeightWatchers, known for its diet programs once endorsed by celebrities including Oprah Winfrey, has filed for bankruptcy after struggling to compete with new weight-loss drugs like Ozempic.

She has the most common fatal genetic disease in the U.S., which afflicts ... the Cystic Fibrosis Foundation says, delivering a new, correct version of the CFTR gene to cells.

TORONTO - A new guideline for treating obesity in children and adolescents says medication can be helpful, but that health providers should prioritize addressing nutrition, exercise and ...

That kind of collaborative and inclusive approach should be what all doctors and nurses take when treating children struggling with obesity, say the authors of new Canadian clinical practice ...

Health care professionals who treat kids with obesity have a new set of guidelines. The guidelines give evidence-based recommendations for how to approach treatment. Obesity is a chronic disease ...

What finally worked was when a team of doctors, dietitians, specialists and psychologists at Toronto's Hospital for Sick Children started telling him about the psychological and genetic ... struggling ...